Follow-up protocols for women with cervical cancer after primary treatment

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 11, 2013, Pages

  Lanceley, Anne ^a   Fiander, Alison ^b   Mccormack, Mary ^c   Bryant, Andrew ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ANAMNESIS; ANXIETY; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECHOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS PYELOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PAPANICOLAOU TEST; POSITRON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REVIEW; THORAX RADIOGRAPHY; UTERINE CERVIX CANCER; ADULT; AFTERCARE; CLINICAL PROTOCOL; UTERINE CERVIX TUMOR;

ADULT; AFTERCARE; CLINICAL PROTOCOLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; UTERINE CERVICAL NEOPLASMS;

EID: 84893457224     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008767.pub2     Document Type: Review

References (47)

1. American Cancer Society. Global Cancer Facts and Figures. 2nd Edition. Atlanta: American Cancer Society, 2011.
2. Amit A, Beck D, Lowenstein L, Lavie O, Bar Shalom R, Kedar Z, et al. The role of hybrid PET/CT in the evaluation of patients with cervical cancer. Gynecologic Oncology 2006;100(1):65-9.
3. Ansink A, de Barros Lopes A, Naik R, Monaghan JM. Recurrent stage IB cervical carcinoma: evaluation of the effectiveness of routine follow up surveillance. British Journal of Obstetrics & Gynaecology 1996;104(7):1156-8.
4. Barnhill D, O Connor D, Farley J, Teneriello M, Armstrong D, Park R. Clinical surveillance of gynecologic cancer patients. Gynecological Oncology 1992;46(3):275-80.
5. Bodurka Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, et al. Post-therapy surveillance of women with cervical cancer. An outcomes analysis. Gynecologic Oncology 2000;78:187-93.
6. Bradley E, Pitts M, Redman C, Calvert E, Howells R, Wafai C. What are the factors associated with the follow-up preferences of women in long-term remission from gynaecological cancer?. Journal of Obstetrics and Gynaecology 2000;20(4):408-11.
7. Brookes RA, Rader JS, Dehdshati F, Mutch DG, Powell MA, Thaker PH, et al. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynaecologic Oncology 2009;112(1):104-9.
8. Cancer Reaserch UK. CancerStats: Cancer Statistics for the UK. http://info.cancerresearchuk.org/cancerstats.
9. Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, et al. Second cancers among 104, 760 survivors of cervical cancer: evaluation of long-term risk. Journal of the National Cancer Instuitute 2007;99:1634-43.
10. Chung HH, Jo H, Kang WJ, Kim JW, Park NH, Song YS, et al. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence. Gynecologic Oncology 2007;104(3):529-34.
11. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd edition. London: BMJ Publication Group, 2001.
12. Der Simonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
13. Duyn A, Van Eijkeren M, Kenter G, Zwinderman K, Ansink A. Recurrent cervical cancer; detection and prognosis. Acta Obstetricia et Gynecologica Scandinavica 2002;81:351-5.
14. Elit L, Fyles AW, Devries MC, Oliver TK, Fung-Kee-Fung M. Follow-up for women after treatment for cervical cancer: a systematic review. Gynecologic Oncology 2009;114:528-35.
15. Elit L, Fyles A, Fung-Kee-Fung M, Oliver T. Gynecology Cancer Disease Site Group. Follow-up for women after treatment for cervical cancer. Program in Evidence-Based Care: Evidence-Based Series. Vol. 4-16, Toronto, Ontario, Canada: Cancer Care Ontario, 2009.
16. Percorelli S, FIGO Committee on Gynaecological Oncology. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. International Journal of Gynaecological Oncology 2009;105(2):103-4.
17. Forni F, Ferrandina G, Deodato F, Macchia G, Morganti AG, Smaniotto D, et al. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness. International Journal of Radiation Oncology Biology Physics 2007;69(4):1145-9.
18. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10 2010; Vol. International Agency for Research on Cancer:http://globocan.iarc.fr.
19. Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, et al. Routine follow up of breast cancer in primary care: randomised trial. British Medical Journal 1996;3(13):665-9.
20. Haie-Meder C, Morice P, Castiglione M, on behalf of the ESMO Guidelines Working Group. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2010;21(Suppl 5):v37-40.
21. Herzog TJ, Wrigth JD. The impact of cervical cancer on quality of life-the components and means for management. Gynaecologic Oncology 2007;107(3):572-7.
22. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557-60.
23. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
24. Hricak H, Powell CB, Yu KK, Washington E, Subak LL, Stern JL, Cisternas MG, Arenson RL. Invasive cervical carcinoma: role of MR imaging in pretreatment work-up--cost minimization and diagnostic efficacy analysis. Radiology 1996;198(2):403-9.
25. Jefford M, Rowland J, Grunfeld E, Richards M, Maher J, Glaser A. Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA. British Journal of Cancer 2013;108:14-20.
26. Krebs HB, Helmkamp BF, Sevin BU. Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection. Journal of Obstetrics and Gynaecology 1982;59:422.
27. Kerr-Wilson RH, McCrum A. Follow-up of patients with gynaecological cancer. Australian & New Zealand Journal of Obstetrics & Gynaecology 1995;35(3):298-9.
28. Kesic V. Management of cervical cancer. European Journal of Surgical Oncology 2006;32:832-7.
29. Kew FM, Roberts AP, Cruickshank DJ. The role of routine follow-up after gynecological malignancy. International Journal of Gynecological Cancer 2005;15(3):413-9.
30. Kew FM, Cruickshank DJ. Routine follow up after treatment for a gynaecological cancer: a survey of practice. International Journal of Gynecological Cancer 2006;16:380-4.
31. Kunkler IH, Kerr GR, Ludgate SM. The value of follow-up in stage II carcinoma of the cervix. Clinical Oncology 1991;3(1):28-31.
32. Larson DM, Copeland LJ, Malone JM Jr, Stringer A, Gershenson DM, Edwards CL. Diagnosis of recurrent cervical carcinoma after radical hysterectomy. Journal of Obstetrics and Gynaecology 1988;71(1):6-9.
33. Leeson S, Stuart N, Sylvestre Y, Hall L, Whitaker R. Gynaecological cancer follow-up: national survey of current practice in the UK. British Medical Journal Open 2013;3(doi:10.1136/bmjopen-2013-002859):e002859.
34. Moore S, Corner J, Haviland J, Wells M, Salmon E, Normand C. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. British Medical Journal 2002;325:1145.
35. Morice P, Deyrolled C, Rey A, Atallah D, Pautier P, Camatte S. Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. Annals of Oncology 2004;15:218-23.
36. The National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Cervical Cancer. V3, 2013. NCCN Web-based resource: www.nccn.org.
37. National Cancer Survivorship Inititive. Stratified Pathways of Care, 2013. http://www.ncsi.org.uk/what-we-are-doing/risk-stratified-pathways-of-care/.
38. National Health Service. Cervical Screening Programme-England, 2011-2012. NHS Report 2012.
39. Nobbenhuis MA, Balasubramani L, Kolomainen DF, Barton DP. Surgical management and follow-up of patients with cervical cancer: survey of gynaecological oncologists in the UK. Journal of Obsteterics and Gynaecology 2012;32(6):576-9.
40. Olaitan A, Murdoch J, Anderson R, James J, Graham J, Barley V. A critical evaluation of current protocols for the follow-up of women treated for gynecological malignancies: a pilot study. International Journal of Gynecological Cancer 2001;11(5):349-53.
41. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
42. Samlal R, Ven der Velden J, Van Erden T, Schilthuis MS, Gonzalez D, Lammes FB. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. International Journal of Gynaecological Cancer 1998;8:78-84.
43. Sartori E, Pasinetti B, Carrara L, Gambino A Odicino F, Pecorelli S. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecologic Oncology 2007;107:S241-7.
44. Soisson AP, Gessler G, Soper JT, Berchuck A, Clarke-Pearson DL. A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. Obstetrics & Gynecology 1990;76(1):106-9.
45. Vale CL, Tierney JF, Davidson SE, Drinkwater KJ, Symonds P. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists' audit. Clinical Oncology 2010;22:590-601.
46. Zanagnolo V, Minig LA, Gadducci A, Maggino T, Sartori E, Zola P, et al. Surveillance procedures for patients for cervical carcinoma. International Journal of Gynaecological Cancer 2009;19(3):306-13.
47. Zola P, Fuso L, Mazzola S, Piovano E, Perotto S, Gadducci A, et al. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicentre retrospective analysis. Gynaecologic Oncology 2007;107:S150-4.